Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P01350 (
gastrin
)
9,683
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
In this study, Syndrome of Deficiency revealed that gastric acid secretion, cellular immunity, hematopoietic and synthetic metabolism were all decreased. The RBC, Hb, TG, HDL-C, CD8, infection rate of HP, the degree of atypical hyperplasia and the staining intensity of PNA were different for Spleen-Kidney-Deficiency syndrome from spleen-Deficiency syndrome, the former was lower than the latter, while LPO was higher and
ESR
was faster for the former. Syndrome of Excess revealed that the serum
gastrin
level was higher, humoral immunity and catabolic metabolism were increased, its blood was in hyperviscosity and hypercoagulation state. The Qi Stagnation with Blood Stasis was different from the Qi stagnation alone which including the atrophic degree of the former was severer, the
ESR
was faster than that of the later. The Heat Stagnation (HS), retention of Dampness (RD) and Damp-Heat (DH) have some difference. First, for secretion of gastric acid. HS was the lowest, DH the next, RD the third. Second, for the level of LPO, HS was the highest.
...
PMID:[Deficiency and excess syndrome of chronic atrophic gastritis]. 831 96
We present a case of highly elevated tenfold rise of serum chromogranin A in a young, morbidly obese, hypertensive female being investigated for pancreatic mass, weight loss, and elevated
ESR
. Following extensive noninvasive investigations, an ultrasound-guided pancreatic biopsy confirmed benign haemorrhagic cyst. A clue to the etiology of the hyperchromogranin A was the elevated serum
gastrin
level leading to suspicion of proton pump inhibitor administration confirmed by admittance to its use. Withdrawal of the medication led to dramatic resolution of the neuroendocrine tumor marker.
...
PMID:Malignant Range Elevation of Serum Chromogranin A due to Inadvertent Use of Proton Pump Inhibitor in a Subject with Pancreatic Incidentaloma. 2293 81